Introduction of new NHS vaccination programmes against respiratory syncytial virus (RSV)
Following guidance from the Joint Committee on Vaccination and Immunisation (JCVI), the NHS is rolling out 2 new respiratory syncytial virus (RSV) vaccination programmes from 1 September 2024, for older adults and during pregnancy for infant protection.
RSV is a common respiratory virus that that can cause serious lung infections. While RSV infection can occur at any age, the risk and severity of RSV and its complications are increased in older adults and in neonates and small babies, and it has a considerable impact on individuals and NHS services during the winter months.
For more information on these programmes, please see: